Objective: To identity osteoarthritis(OA) subtypes with gene expression of peripheral blood mononuclear cells.
INTRODUCTION
Osteoarthritis (OA) is a common degenerative joint disorder characterized by pain, stiffness, limitation of movement and disability 1 , of which pain and disability remain the most common outstanding signs and symptoms 2 . It is results from a combination of risk factors, such as increasing age, gender, obesity, knee malalignment, loading of joints, genetics and low-grade systemic inflammation 1, 3, 4 . OA affects approximately 18% of women and 10% of men over 60 years of age 5, 6 . At the same time, the burden resulting from OA is increasing rapidly with an increase in two major risk factors:
ageing population and the epidemics of obesity 7 .
There are currently no disease-modifying osteoarthritis drugs that can be used to treat OA patients. This may be due to the heterogeneity of the OA population, where the disease progression is often poorly understood 8 . Recent researches show that OA has subtypes with joint cartilage transcriptome. Stratification on histopathological features have revealed that the subtypes of OA and new omics technologies have been offered opportunities to analyze different pathogenic mechanisms in the identification of OA subtypes in an unbiased way 9, 10 . In order to gain more understanding of OA heterogeneity, several studies have focused on identification of subtypes by a method of DNA methylation and RNA seq data 10, 11 . However, they both used cartilage samples because gene expression pattern in cartilage reflects the influence of extrinsic systemic and micro environment, and intrinsic chondrocyte responses 10 , of which is difficult to get and can cause secondary damage. 2013). Increased interest in the development of new diagnostic and prognostic tests for early forms of OA may incorporate the use of blood-based biomarkers 8 .
The use of blood-based liquid biopsies has been recommended to overcome limitations of tissue acquisition in the field of cancer research 12, 13 , and the application of blood biomarkers have been used in depression 14 , chronic obstructive pulmonary disease 15 and Alzheimer disease 16 . Distinctive gene expression signature between OA and normal clients has been detected in peripheral blood mononuclear cells (PBMC) sample 17 . These evidence also can provide the clues for analyzing the subtypes of OA with blood samples.
In this study, we want to analyze the gene expression pattern and identify subtypes of OA which was performed by microarray analysis of the Genetics osteoARthritis and Progression (GARP) study and provide a new diagnostic tool for OA subtypes 17 .
METHODS

Data collection
The series matrix file(s) of gene expression data (GSE48556) was download from Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo) which is a case-control study comparing gene expression profiles generated with total messenger RNA obtained from peripheral blood mononuclear cells of controls with that of OA patients from the GARP study 17, 18 .The method of study populations selection and RNA isolation were described according to the study of Ramos et al 17 . Figure 1 showed progress of the study strategy. Series matrix file(s) data was processed and normalized as previously described 17 . Firstly, using R package to analyze the difference between OA and healthy controls and identity the subtypes of OA population. Then analysis the difference between subtypes and find marker genes to distinguish and to diagnose OA subtypes. Finally, classification and accuracy analysis was taken by the use of machine learning.
Analysis strategy
Microarray analysis
ID conversion was performed by annotate package version 1.58.0 and prcomp function in R 3.4.4 was used to perform principal components analysis(PCA).
Differentially expressed genes (DEGs) were identified by limma package version 3.36.1 19 for linear regression analysis which were reported with Benjamini-Hochberg (BH) corrected p-values of ＜0.05 19, 20 .
Unsupervised clustering
Unsupervised clustering was carried out by k-means clustering. Using SC3 package version 1.8.0 which was developed as a tool for the unsupervised clustering of single cell RNA-Seq experiments with full microarray gene expression to analysis 21 .The theory of k-means algorithm could also be adapted into the microarray analysis.
Subtypes identification analysis
Fold changes were calculated with limma package with P values adjusted for multiple testing with Benjamini-Hochberg correction 19 . DEGs were identified with an absolute fold change of ≥1.5 and adjust P value ＜ 0.05. Each subtype identified by the k-means clustering result was compared with healthy controls population to see the difference between subtypes. A support vector machine(SVM) classifier with five-fold cross-validation was performed to distinguish OA subtypes. Models were evaluated by a receiver operating characteristic (ROC) analysis using an area under the curve (AUC) criterion.
KEGG pathway analysis
Gene set enrichment analysis (GSEA) was performed which used desktop application from the Broad Institute (http://www.broad.mit.edu/gsea/) to do the Kyoto Encyclopedia of Genes and Genomes(KEGG) pathway analysis and FDR q value＜ 0.05 which were considered to be of significance 22 .
Analysis of protein interaction networks
To investigate protein interactions among the genes identified in significant KEGG pathway, the search tool for the retrieval of interacting genes/proteins (STRING) 10.5 available online(https://string-db.org/) was used 23 .
Cell type enrichment analysis
xCell is an online tool for cell type enrichment analysis of 64 immune and stromal cell type with gene expression data (http://xcell.ucsf.edu/) 24 . The tissue cellular heterogeneity landscape of subtypes of OA was used this method to digitally portray.
RESULTS
Gene expression pattern in patients with OA and healthy controls
After gene id conversion, 19238 unique genes were presented and PCA analysis visualized the first two principal components and showed huge heterogeneity between OA population (Figure 2A 
Stratification of gene expression between two OA clusters
To cluster and identify the subtypes, unsupervised clustering k-means method by SC3 package was used 21 . The most stable clustering distinguished two subgroups and measure of the degree of fit by consensus matrix and silhouette score revealed a strong identity within each cluster ( Figure 3A) . The gene expression with microarray thus divided the OA patients into two clusters: Group A 56.6% (N=60) and Group B 43.3%
(N = 46). To eliminate subtype differences was due to the crowd itself, we also clustered the healthy controls sample, but results showed healthy controls population are homogeneous in which k estimated to be one ( Figure 3B ). Sixteen differentially expressed genes (DEGs) comparing to the healthy controls population were detected with fold change ≥ 1.5 and the adjust P value < 0.05. However, when the results were divided into Group A and Group B and each group was compared separately with the healthy controls population, an additional 550 DEGs were detected, with 11 of those endemic to Group A and 517 distinctive to Group B ( Figure 4A ). We next want to test whether we can distinguish two main groups by those 11 genes specifically expressed in Group A which ALAS2, CAMP, FAM43A, GPR18, LILRA3 were upregulated and DUSP1, FOS, GNL3L, MAP3K7CL, PDEA4, STK17B were downregulated ( Figure   4B ), but DUSP1 (P = 0.42) and PDE4C (P = 0.132) did not have significant statistical difference using Student's t test. The information of nine genes were collected by Gene Cards (http://www.genecards.org/) ( Table 1) . Then we used to train a SVM classifier with fivefold cross-validation using these nine genes to predict the subtypes with the result of an area under the curve of 0.99 ( Figure 4C ). 
Table1 General information of the marker gene distinguish Group
KEGG pathway analysis in subtypes
We then performed GSEA analysis to identify KEGG pathways that are enriched in each group 22 . In contrast to ontology analysis, this algorithm is based on the usage of all gene expression data and derives its function from the analysis of a coordinated sets of genes regulated in a defined biological process or pathway 25 . This identified in Group A changed in Glycosaminoglycan biosynthesis, Porphyrin and chlorophyll metabolism, Glycine serine and threonine metabolism and apoptosis, and Group B changed in Graft versus host disease and Antigen processing and presentation ( Figure   5A ). Using STRING, we visualized multiple interactions between proteins involved in the significant pathways ( Figure 5B ). To the best of our knowledge, this is the first paper to utilize blood sample for the analysis of OA subtypes and provide a new insight to research the pathological mechanism of OA. However, this study has some limitations. Our data analysis in based on the GEO data and we cannot get the primary clinical outcomes of the OA patients, so we cannot be sure that the subtype has no association with clinical severity and disease stage. Also, as the limitation of accessing primary data, we cannot adjust the possible batch effects and the result of DEGs between OA and healthy controls which was different form the study of Ramos et al 17 , and the quantitative RT-PCR to validate and replicate the results of the subtype could not either be made use of.
Cell type enrichment in Group
Our study provides a new insight of OA identification and the basic research of OA, but the classifier panel of genes and potential biomarkers in blood requires further validation and testing. Follow-up investigations are needed to confirm potential predictive value, and the result and conclusion need to be replicated and validated by RNA-seq data.
